ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2724

A Prospective Study of Ankylosing Spondylitis in China with Smart Management System for Spondyloarthritis: Study Design and Baseline Characteristics of the 449 Recruited Patients

Xiaojian Ji, Qiongfang Wen, Jinshui Yang, Jian Zhu, Jianglin Zhang and Feng Huang, Rheumatology, Chinese PLA General Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS) and chronic disease care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   The aim of this study was to set up a large, longitudinal and prospective database to investigate the epidemiology, pathogenesis, diagnosis, and prognosis of ankylosing spondylitis (AS) through mobile health in the Chinese population.

Methods:   449 consecutive outpatients with confirmed AS or spondyloarthritis (SpA) were recruited and followed annually with Smart Management System for SpA (SMSP). Characteristics of registration and demography (age, gender, time of back pain onset, diagnosis, presence of AS-related clinical manifestations, family history) and the current condition (disease activity, severity, treatments, laboratory tests) were collected online with SMSP.

Results:   449 patients (mean age: 29.4±8.5 years, male 84.0 %, HLA-B27 positive rate 81.2%) were included in the analysis. In this cross-sectional analysis, only data at the first visit were used (from May 2014 to December 2014). A history or current symptoms suggestive of peripheral arthritis, enthesitis, acute anterior uveitis, psoriasis and inflammatory bowel disease were observed in 46.4%, 69.1%, 10.5%, 2.4% and 5.8% of the patients, respectively. Differences in symptom duration (≤ 5 years, 5 years to 10 years and > 10 years) were analyzed. The 3 groups did not differ in the frequency of gender, HLA-B27 positivity, family history, arthritis, enthesitis, inflammatory bowel disease, psoriasis, and abnormal CRP. Pain located in thoracic spine (34.1%), anterior chest wall pain (28.1%) and uveitis (18.5%) were detected significantly more frequently in patients with symptom duration of > 10 years.

The association of clinical variables and laboratory markers with patient’s poor physical mobility (lumbar flexion Impairment, cervical flexion Impairment and chest activity limitation) was evaluated with multivariate logistic regression model. The result revealed that 121 patients (26.9 %) had reduced lumbar mobility; 93 patients (20.7 %) had impaired cervical flexion and 104 patients (23.2 %) had reduced chest expansion. The analyses showed that symptom duration is independently associated with poor physical mobility of any of the body parts mentioned above (OR = 1.11, OR = 1.14, OR = 1.13, respectively). Age at onset is only significantly associated with chest expansion limitation (OR = 1.06). Cervical spine pain at onset is determined to be closely related to cervical flexion impairment (OR = 1.98). Also, smokers and ASDAS are determined to have an unfavorable effect upon outcomes of cervical flexion (OR=2.06, OR = 1.38, respectively). Smokers, abnormal CRP, and ASDAS correlate with a poor prognosis in lumbar flexion (OR = 2.44, OR = 2.05, OR =1.45, respectively).

Conclusion:   This is the first prospective cohort study of ankylosing spondylitis and the first smart management system for SpA in China. With increasing global popularity of smart phone technology, there is a great opportunity for using mobile phone applications for disease management. This large cohort may improve our knowledge on the characteristics, pathogenesis and natural course in Chinese patients with AS.


Disclosure: X. Ji, None; Q. Wen, None; J. Yang, None; J. Zhu, None; J. Zhang, None; F. Huang, None.

To cite this abstract in AMA style:

Ji X, Wen Q, Yang J, Zhu J, Zhang J, Huang F. A Prospective Study of Ankylosing Spondylitis in China with Smart Management System for Spondyloarthritis: Study Design and Baseline Characteristics of the 449 Recruited Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/a-prospective-study-of-ankylosing-spondylitis-in-china-with-smart-management-system-for-spondyloarthritis-study-design-and-baseline-characteristics-of-the-449-recruited-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-prospective-study-of-ankylosing-spondylitis-in-china-with-smart-management-system-for-spondyloarthritis-study-design-and-baseline-characteristics-of-the-449-recruited-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology